Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0197 (-3.13%)
At close: Apr 2, 2026

Vaxart Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
237.2628.77.380.110.89
Revenue Growth (YoY)
726.68%288.94%6796.26%-88.00%-77.95%
Cost of Revenue
201.5874.2168.1481.0548.75
Gross Profit
35.68-45.51-60.76-80.95-47.86
Selling, General & Admin
17.6120.7822.5829.3921.89
Operating Expenses
17.6120.7822.5829.3921.89
Operating Income
18.07-66.29-83.35-110.33-69.75
Interest Expense
-2.82-2.97-1.45-1.31-1.48
Interest & Investment Income
1.62.542.651.250.08
Currency Exchange Gain (Loss)
-----0
Other Non Operating Income (Expenses)
-0.040.03-0.06-0.01-
EBT Excluding Unusual Items
16.8-66.69-82.2-110.4-71.15
Asset Writedown
----4.25-3.01
Other Unusual Items
---6.963.79
Pretax Income
16.8-66.69-82.2-107.69-70.36
Income Tax Expense
0.480.260.260.070.11
Net Income
16.33-66.95-82.47-107.76-70.47
Net Income to Common
16.33-66.95-82.47-107.76-70.47
Shares Outstanding (Basic)
230202145128121
Shares Outstanding (Diluted)
230202145128121
Shares Change (YoY)
13.96%39.58%13.42%5.13%37.55%
EPS (Basic)
0.07-0.33-0.57-0.84-0.58
EPS (Diluted)
0.07-0.33-0.57-0.84-0.58
Free Cash Flow
7.57-45.32-72.32-104.38-64.99
Free Cash Flow Per Share
0.03-0.22-0.50-0.82-0.54
Gross Margin
15.04%-158.58%---
Operating Margin
7.62%-230.99%-1129.52%-103114.95%-7819.17%
Profit Margin
6.88%-233.27%-1117.56%-100708.41%-7900.22%
Free Cash Flow Margin
3.19%-157.90%-980.13%-97551.40%-7285.76%
EBITDA
26.65-57.44-74.72-104.53-65.54
EBITDA Margin
11.23%-200.15%---
D&A For EBITDA
8.588.858.625.814.21
EBIT
18.07-66.29-83.35-110.33-69.75
EBIT Margin
7.62%-230.99%---
Effective Tax Rate
2.83%----
Revenue as Reported
237.2628.77.380.110.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.